Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Angew Chem Int Ed Engl ; 56(13): 3579-3584, 2017 03 20.
Artigo em Inglês | MEDLINE | ID: mdl-28198119

RESUMO

Metal complex catalysis within biological systems is largely limited to cell and bacterial systems. In this work, a glycoalbumin-AuIII complex was designed and developed that enables organ-specific, localized propargyl ester amidation with nearby proteins within live mice. The targeted reactivity can be imaged through the use of Cy7.5- and TAMRA-linked propargyl ester based fluorescent probes. This targeting system could enable the exploitation of other metal catalysis strategies for biomedical and clinical applications.


Assuntos
Complexos de Coordenação/química , Corantes Fluorescentes/química , Ouro/química , Albumina Sérica/química , Animais , Catálise , Complexos de Coordenação/farmacocinética , Corantes Fluorescentes/farmacocinética , Produtos Finais de Glicação Avançada , Ouro/farmacocinética , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Imagem Óptica/métodos , Albumina Sérica/farmacocinética , Distribuição Tecidual , Albumina Sérica Glicada
2.
Chemistry ; 22(41): 14707-16, 2016 Oct 04.
Artigo em Inglês | MEDLINE | ID: mdl-27557614

RESUMO

A bio-inspired cascade reaction has been developed for the construction of the marine natural product ageladine A and a de novo array of its N1-substituted derivatives. This cascade features a 2-aminoimidazole formation that is modeled after an arginine post-translational modification and an aza-electrocyclization. It can be effectively carried out in a one-pot procedure from simple anilines or guanidines, leading to structural analogues of ageladine A that had been otherwise synthetically inaccessible. We found that some compounds out of this structurally novel library show a significant activity in modulating the neural differentiation. Namely, these compounds selectively activate or inhibit the differentiation of neural stem cells to neurons, while being negligible in the differentiation to astrocytes. This study represents a successful case in which the native biofunction of a natural product could be altered by structural modifications.


Assuntos
Células-Tronco Neurais/citologia , Neurônios/efeitos dos fármacos , Pirróis/síntese química , Compostos de Anilina/química , Animais , Biomimética/métodos , Diferenciação Celular , Guanidinas/química , Humanos , Imidazóis/química , Camundongos , Estrutura Molecular , Neurônios/citologia , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Proteínas Tirosina Quinases/antagonistas & inibidores , Pirróis/farmacologia , Bibliotecas de Moléculas Pequenas/síntese química , Relação Estrutura-Atividade , Quinases Dyrk
3.
Chem Sci ; 12(37): 12266-12273, 2021 Sep 29.
Artigo em Inglês | MEDLINE | ID: mdl-34603656

RESUMO

Selective cell tagging (SeCT) therapy is a strategy for labeling a targeted cell with certain chemical moieties via a catalytic chemical transformation in order to elicit a therapeutic effect. Herein, we report a cancer therapy based on targeted cell surface tagging with proapoptotic peptides (Ac-GGKLFG-X; X = reactive group) that induce apoptosis when attached to the cell surface. Using either Au-catalyzed amidation or Ru-catalyzed alkylation, these proapoptotic peptides showed excellent therapeutic effects both in vitro and in vivo. In particular, co-treatment with proapoptotic peptide and the carrier-Ru complex significantly and synergistically inhibited tumor growth and prolonged survival rate of tumor-bearing mice after only a single injection. This is the first report of Ru catalyst application in vivo, and this approach could be used in SeCT for cancer therapy.

4.
Sci Adv ; 7(17)2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-33893089

RESUMO

This study presents the early framework of selective cell tagging (SeCT) therapy, which is the concept of preferentially labeling specific cells in vivo with chemical moieties that can elicit a therapeutic response. Using glycosylated artificial metalloenzyme (GArM)-based protein labeling, this study reports two separate functional strategies. In one approach, early tumor onset can be suppressed by tagging cancer cells in living mice with an integrin-blocking cyclic-Arg-Gly-Asp (cRGD) moiety, thereby disrupting cell adhesion onto the extracellular matrix. In another approach, tumor growth in mice can be reduced by tagging with a cytotoxic doxorubicin moiety. Subsequent cell death occurs following internalization and drug release. Overall, experiments have shown that mouse populations receiving the mixture of SeCT labeling reagents exhibited a significant delay/reduction in tumor onset and growth compared with controls. Highlighting its adaptability, this work represents a foundational step for further development of SeCT therapy and its potential therapeutic applications.

5.
Chem Commun (Camb) ; 53(60): 8403-8406, 2017 Jul 25.
Artigo em Inglês | MEDLINE | ID: mdl-28589196

RESUMO

Rapidly growing cancer cells have increased levels of intracellular polyamines compared to normal, healthy tissues. Based on the selective reactivity of glycine propargyl esters, probes were synthesized that show evidence for selective polyamine reactivity, which was then applied for selective cancer cell imaging studies.

6.
Adv Sci (Weinh) ; 4(2): 1600394, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-28251056

RESUMO

Structurally well-defined heterogeneous N-glycoclusters are prepared on albumin via a double click procedure. The number of glycan molecules present, in addition to the spatial arrangement of glycans in the heterogeneous glycoclusters, plays an important role in the in vivo kinetics and organ-selective accumulation through glycan pattern recognition mechanisms.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA